TY  - GEN
AU  - Xiao, Qingyang
AU  - Nobre, André
AU  - Piñeiro, Pilar
AU  - Berciano-Guerrero, Miguel-Ángel
AU  - Alba, Emilio
AU  - Cobo, Manuel
AU  - Lauschke, Volker M.
AU  - Barragán, Isabel
PY  - 2020
DO  - 10.3390/jcm9010286
UR  - http://hdl.handle.net/20.500.12105/17990
AB  - Checkpoint inhibitor therapy constitutes a promising cancer treatment strategy that targets the immune checkpoints to re-activate silenced T cell cytotoxicity. In recent pivotal trials, immune checkpoint blockade (ICB) demonstrated durable responses...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - Immunotherapy
KW  - Predictor
KW  - Resistance
KW  - Epigenetics
KW  - Stroma
KW  - Melanoma
KW  - Non-small-cell lung cancer
KW  - Inmunoterapia
KW  - Predicción
KW  - Inhibidores de puntos de control inmunológico
KW  - Epigenómica
KW  - Carcinoma, non-small-cell lung
KW  - Epigenomics
KW  - Humans
KW  - Prognosis
KW  - DNA Methylation
KW  - Immune Evasion
KW  - Immunotherapy
KW  - Neoplasms
KW  - Biological Markers
KW  - Mutation
KW  - Epigenesis, Genetic
KW  - T-Lymphocytes|DNA
TI  - Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response
TY  - review article
ER  -